FDA Litigation Updates: Navigating Post-Chevron and a New Administration (On-Demand Webinar)
Date: 03/27/25
Closed captions are available.
Overview: This 90-minute webinar explores current litigation trends involving FDA-regulated products, focusing on recent lawsuits and regulatory enforcement actions. The speakers also examine the impact of the Supreme Court’s recent decision to overturn Chevron deference and discuss strategic considerations for resolving disputes with the agency, especially considering potential shifts under the new presidential administration.
Learning Objectives:
- Gain insights into the potential challenges and strategic considerations associated with marketing an FDA-regulated product and resolving disputes with FDA.
- Learn about recent FDA warning letters, enforcement actions, and lawsuits involving FDA regulated products.
- Evaluate considerations about agency authority, policies, and enforcement priorities under the new administration.
Speaker Information:
Rachel Gartner, Partner, Holland & Knight
Chad Landmon, Shareholder, Polsinelli
Credit Information:
CLE: The maximum number of credits available for ON DEMAND is 1.5 for a 60-minute state and 1.8 for a 50-minute state. Please note that the availability of credits may vary from state to state. This self-study course will be available for purchase for approximately one year after the recording date, but state rules on duration of eligibility for CLE-credits differ, so please check with your state before purchasing self-study offerings.
CPE: CPE credits are not available for on-demand.
CCB: CCB credits are not available for this on-demand webinar.
For additional information, please visit the AHLA Continuing Education page.
Also available from AHLA: